Streetbeat News

Price Targets

MITK

Craig-Hallum analyst Chad Bennett maintains a Buy rating on Mitek Systems (MITK) and raises the price target from $17 to $19.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 4:26 pm

VUZI

Craig-Hallum analyst Christian Schwab maintains a Buy rating on Vuzix (NASDAQ:VUZI) but lowers the price target from $3.5 to $3.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 4:23 pm

CMPX

HC Wainwright & Co. analyst Joseph Pantginis reiterates a Buy rating on Compass Therapeutics (NASDAQ:CMPX) and maintains a $10 price target.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 4:20 pm

AMBA

B of A Securities analyst Vivek Arya maintains an Underperform rating on Ambarella (NASDAQ:AMBA), lowering the price target from $62 to $50.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 4:17 pm

ANAB

Leerink Partners analyst David Risinger has initiated coverage on AnaptysBio (NASDAQ:ANAB) with an Outperform rating and set a price target of $47.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 4:10 pm

GFS

B of A Securities analyst Vivek Arya maintains a Neutral rating on GLOBALFOUNDRIES (NASDAQ:GFS) and lowers the price target from $62 to $55.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 4:08 pm

SNPO

JP Morgan analyst Cory Carpenter downgrades Snap One Holdings (NASDAQ:SNPO) from Overweight to Neutral and lowers the price target from $11 to $10.75.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 4:06 pm

XNCR

BTIG analyst Kaveri Pohlman has maintained a Buy rating on Xencor (NASDAQ:XNCR) but has lowered the price target from $56 to $38.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 4:04 pm

AVTX

Avalo Therapeutics' stock price increased following an upgrade by Oppenheimer from Perform to Outperform, with a new price target set at $35.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 4:02 pm